Mineralys Therapeutics, Inc. Common Stock (MLYS) — Financial Flexibility Index
Mineralys Therapeutics, Inc. Common Stock (MLYS) has a Financial Flexibility Index of -2.68x as of March 2026. Free cash flow of $-39.47 Million (operating CF $-39.47 Million minus capex $0.00) represents -3% of total liabilities ($14.72 Million). Also explore net asset growth rate of Mineralys Therapeutics, Inc. Common Stoc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mineralys Therapeutics, Inc. Common Stock Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Mineralys Therapeutics, Inc. Common Stock across 6 annual periods. Check MLYS capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Mineralys Therapeutics, Inc. Common Stock (2020–2025)
Year-by-year free cash flow to debt coverage for Mineralys Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see Mineralys Therapeutics, Inc. Common Stoc (MLYS) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -9.42x | $-142.40 Million | $-142.42 Million | $15.11 Million | ▲ +17.0% |
| 2024 | -11.35x | $-166.22 Million | $-166.31 Million | $14.65 Million | ▼ -46.6% |
| 2023 | -7.74x | $-81.17 Million | $-81.17 Million | $10.48 Million | ▼ -4318.1% |
| 2022 | -0.18x | $-29.22 Million | $-29.22 Million | $166.71 Million | ▲ +59.0% |
| 2021 | -0.43x | $-14.56 Million | $-14.56 Million | $34.05 Million | ▲ +11.8% |
| 2020 | -0.48x | $-2.46 Million | $-2.46 Million | $5.08 Million | — |